Healthcare M&A Case Interview: Worked Acquisition Case
| Case type | M&A |
|---|---|
| Industry | Healthcare / Digital Health |
| Difficulty | Medium |
| Firm style | BCG |
What does this healthcare M&A case ask you to decide?
Our client, HarborHealth, is a regional outpatient care network evaluating the acquisition of MedLink Virtual Care, a fast-growing telehealth provider. MedLink's shareholders are asking for an enterprise value of $420M. The CEO wants to know whether this deal should proceed and under what conditions it creates value.
HarborHealth operates 95 outpatient clinics across the U.S. Midwest and wants to expand into hybrid care models. MedLink provides virtual urgent-care visits and chronic-care monitoring, with a strong digital front-end but weaker payer contracting capabilities. Management believes there is strategic fit, but needs a clear view on valuation, realistic synergies, and integration risk before signing.
Which exhibits drive the acquisition math?
Exhibit 1
MedLink Financial Performance, 2022-2024 ($M)
MedLink revenue, EBITDA, and EBITDA margin by year ($M), 2022-2024.
Show the data behind Exhibit 1
| Year | Revenue ($M) | EBITDA ($M) | EBITDA Margin (%) |
|---|---|---|---|
| 2022 | 120 | 12 | 10% |
| 2023 | 150 | 18 | 12% |
| 2024 | 180 | 25 | 14% |
Exhibit 2
Trading Multiples vs Growth (Public Digital-Health Peers, peer median 14.0x)
EV/EBITDA multiple (x) vs revenue growth (%) for public digital-health peers. Peer median: 14.0x at 14% growth. MedLink revenue growth: 20%.
Show the data behind Exhibit 2
| Company | Revenue Growth (%) | EV/EBITDA (x) |
|---|---|---|
| Peer A | 9 | 11.0 |
| Peer B | 12 | 13.0 |
| Peer C | 14 | 14.0 |
| Peer D | 14 | 14.0 |
| Peer E | 17 | 15.5 |
| Peer F | 19 | 16.0 |
| Peer Median | 14 | 14.0 |
| MedLink | 20 | To calculate |
Exhibit 3
Value Bridge to Maximum Justified Offer ($M)
Value bridge from Standalone EV to Maximum Justified EV ($M), showing synergy value added and integration costs deducted.
Show the data behind Exhibit 3
| Driver | Assumption | Value ($M) |
|---|---|---|
| Standalone EV | 2024 EBITDA $25M x 14.0x peer median | 350 |
| Synergy Value | Run-rate synergies $18M x 70% capture x 10x multiple | 126 |
| Integration Costs | One-time integration costs | -45 |
Exhibit 4
Integration Risk Assessment (1=Low, 5=High)
Primary concern by workstream: Data Privacy Compliance, HIPAA compliance and cybersecurity exposure; Tech Migration, platform downtime and interoperability risk; Provider Contracting, payer renegotiation complexity; Brand Harmonization, patient confusion during transition; Clinical Protocols, different care pathways across virtual and in-person teams.
Show the data behind Exhibit 4
| Workstream | Risk Score (1-5) | Primary Concern |
|---|---|---|
| Clinical Protocols | 2 | Different care pathways across virtual vs in-person teams |
| Provider Contracting | 3 | Payer renegotiation complexity |
| Tech Migration | 4 | Platform downtime and interoperability risk |
| Data Privacy Compliance | 5 | HIPAA compliance and cybersecurity exposure |
| Brand Harmonization | 3 | Patient confusion during transition |
BCGM&A · medium
HarborHealth Acquisition of MedLink Virtual Care
Healthcare / Digital Health
How a strong candidate structures it
A strong M&A structure could cover four areas
Question by question
- 1
Case context
Understand the Case
“Could you briefly restate the client situation and the core decision we need to make?”
- 2
Clarifying
Clarifying Questions
“What clarifying questions would you ask before building your approach?”
- 3Drill the structure
Structure
Framework
“How would you structure your analysis for this M&A decision? Tell me where you would start your investigation and why.”
- 4Drill the brainstorming
Analysis
Strategic Rationale Brainstorm
“Before looking at detailed valuation math, brainstorm the main strategic reasons this deal could create value, and what you would test first.”
- 5Drill the math
Math
Valuation Benchmarking
“Using Exhibits 1 and 2, what EV/EBITDA multiple is implied by the $420M asking price, and how does it compare with peers?”
- 6Drill the math
Math
Maximum Justified Offer
“Now use Exhibit 3 to calculate the maximum justified enterprise value and whether paying $420M creates value in base case.”
- 7Drill the brainstorming
Analysis
Integration Risk and Guardrails
“Using Exhibit 4, what are the top integration risks, and what guardrails would you set before closing?”
- 8Drill the synthesis
Synthesis
Final Recommendation
“What is your final recommendation to HarborHealth's CEO on this acquisition?”
The worked path
The numbers that decide it
- Revenue rises from $120M to $180M and EBITDA from $12M to $25M; the 2024 margin is 25 / 180 = 13.89%, rounded to 14%.
- Asking EV of $420M divided by $25M EBITDA is 16.8x, 20% above the 14x peer median.
- The $350M standalone benchmark plus $126M adjusted synergy value minus $45M integration costs gives $431M.
- The $420M price leaves $11M of modeled headroom.
- Capture break-even is 63.89% with the other bridge assumptions fixed.
- The highest listed integration risks are privacy at 5 and technology at 4; these scores are priorities, not probabilities.
- Proceed, renegotiate or decline based on diligence and margin of safety; financing capacity does not establish value.
Final synthesis
Separate standalone valuation from deal-specific value. Use $25M EBITDA x the 14x public trading median = $350M. Add $18M run-rate synergies x 70% capture x 10 = $126M once, then subtract $45M integration costs to obtain $431M. At the $420M ask, the $11M buffer is thin. Capture break-even = (420 - 350 + 45) / 180 = 63.8889%, with other assumptions fixed; this is not an independent probability estimate. Test standalone quality, synergy timing and integration budgets, then examine privacy and technology risks before commitment. The 14% margin is rounded from 25 / 180. Do not treat public peers as completed acquisition transactions or the $450M financing capacity as a justified bid. Negotiate below modeled value and update the bridge for diligence findings. A conditional rejection is valid if risk remains unresolved.
BCGM&A · medium
HarborHealth Acquisition of MedLink Virtual Care
Healthcare / Digital Health
Why this case
This scenario tests whether you can distinguish strategic fit from a price you can defend. Unlike a generic M&A case, it combines a digital front-end with a physical care network, so payer contracting, HIPAA exposure, technology migration, and clinical handoffs matter to value. The key trap is accepting a premium for growth without stress-testing synergy capture and integration governance. The case rewards a conditional recommendation, not reflexive yes or no.
FAQ
- How do you value the target in this healthcare M&A case interview?
- Start with MedLink’s standalone earnings, then benchmark the asking multiple against digital-health peers. Its 2024 EBITDA is $25M, and the peer median is 14.0x, implying standalone value of about $350M. Then add only credible, probability-adjusted synergies and subtract one-time integration costs before setting a maximum offer.
- What makes the $420M offer acceptable?
- The value bridge reaches a maximum justified enterprise value of $431M: $350M standalone value, plus $126M of synergy value, less $45M of integration costs. That leaves roughly $11M of headroom at the asking price. A strong recommendation still demands negotiation room and a hard ceiling because the margin of safety is narrow.
- Which healthcare integration risks matter most?
- Data privacy compliance is the highest-risk workstream, with a risk score of 5, followed by technology migration at 4. The practical concerns are HIPAA and cybersecurity exposure, plus platform downtime and interoperability. Set readiness gates, named owners, and phased migration milestones before closing or releasing any contingent consideration.
- How should you structure the recommendation?
- Use four lenses: strategic fit, standalone valuation, synergy value, and integration feasibility. Explain why buying the digital capability beats building or partnering, test whether the premium is supported, quantify net value after costs, and finish with deal guardrails. Recommend a conditional yes only if diligence confirms the technology and compliance plan.
BCGM&A · medium
HarborHealth Acquisition of MedLink Virtual Care
Healthcare / Digital Health